News, References & Resources

News

May 5, 2021

IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO

Infectious disease continues to be a leading cause of illness, morbidity and mortality around the world. In the fight to better understand all pathogens, including the SARS-CoV-2 lineage and its mutations, IDbyDNA, the pioneer in Precision Metagenomics, is focused on broadening availability for its Next-Generation Sequencing (NGS) targeted products. With that, the company has appointed NGS leader Neil Gunn as its new CEO to drive the next phase of growth.

+ read more about IDbyDNA Appoints Next-Gen Sequencing Executive Neil Gunn as New CEO

Events

Publications

Posters

Podcasts, Webinars & CME

Clinical Research

Case Studies

July 8, 2020

Prevotella pleuriditis Infection Diagnosed in a 12-year-old Male With Progressive Pleurisy and Pneumonia Complicated by Pleural Effusion

A 12-year-old male with type II diabetes presenting with pleurisy and lung infiltrates failed to respond to multiple antibiotics as his condition worsened. Explify® Respiratory identified a rare anaerobic bacterium, Prevotella pleuriditis, in his pleural fluid, and the patient improved on directed therapy.

+ read more about Prevotella pleuriditis Infection Diagnosed in a 12-year-old Male With Progressive Pleurisy and Pneumonia Complicated by Pleural Effusion

June 29, 2020

Pulmonary Coccidioidomycosis Diagnosed by Next-Generation Sequencing (Explify) in an Adolescent with Type 1 Diabetes

An adolescent male admitted to a Texas hospital for ketoacidosis co-presented with productive cough with hemoptysis and lung opacities. Tests for TB, invasive fungi, and next-generation sequencing of plasma cell-free DNA were negative. Explify® Respiratory identified Coccidioides immitis in sputum.

+ read more about Pulmonary Coccidioidomycosis Diagnosed by Next-Generation Sequencing (Explify) in an Adolescent with Type 1 Diabetes

Technical Papers